Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenomics in endocrinology

Richard D Hockett1, Sandra C Kirkwood, Bruce H Mitlak

  • 1Eli Lilly & Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. hockett@lilly.com

The Journal of Clinical Endocrinology and Metabolism
|June 7, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of Potential Sources of Variability on the Analytical Performance of a Circulating Tumor DNA Minimal Residual Disease Test for B-Cell Lymphomas.

Journal of clinical laboratory analysis·2026
Same author

The effect of abaloparatide on the proximal femur in men with osteoporosis assessed by three-dimensional dual-energy X-ray absorptiometry.

JBMR plus·2025
Same author

Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies.

Oncotarget·2025
Same author

Probability of achieving bone mineral density treatment targets with abaloparatide and teriparatide.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025
Same author

Effect of abaloparatide on fracture incidence and bone mineral density in postmenopausal women with osteoporosis at highest risk for fracture.

Menopause (New York, N.Y.)·2025
Same author

Bone turnover markers predict changes in bone mineral density in men treated with abaloparatide: results from the abaloparatide for the treatment of men with osteoporosis (ATOM) study.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025